Remove 2017 Remove Healthcare Provider Remove Side effects
article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen. Regarding both common cold and headache, they are as well among the side effects reported for similar drugs.

article thumbnail

Elevating Patient Experiences by Breaking Down Internal Silos

PM360

Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs). And with therapy underway, many of these programs help boost adherence¹ by addressing common barriers to compliance, like missed doses, side effects, and unreliable information about the drug and disease.²

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. The same can be said for the US.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. The same can be said for the US.

Medical 98